pre-update Archives

On-Demand Webinar

Streamlining Pharmacokinetic Data Management with Certara’s Integral

The PK scientist's data pipeline handles a range of raw data types, including SAS, R,…

CertaraOctober 27, 2023

Blog

How Biosimulation & AI Tech Could Solve Pharma’s R&D Productivity Crisis

Drug development continues to be painfully slow and mind-bogglingly expensive. In a 2010 article, Stephen…

CertaraOctober 27, 2023

Brochure

Certara QSP Designer Technology

User-driven, graphical workspace to optimize collaboration for all stakeholders

CertaraOctober 25, 2023

Blog

Advancing Rectal Drug Delivery: A Breakthrough in Physiologically Based Pharmacokinetic Modeling

This blog explains how Certara’s Simcyp team developed and tested a model in the Simcyp…

CertaraOctober 20, 2023

On-Demand Webinar

RAPS Sponsored Webcast: Leveraging Today’s Technology to Accelerate Submissions: Real Life Examples and Lessons Learned

As the drug development industry strives to accelerate submission timelines and improve patient access to…

CertaraOctober 18, 2023

On-Demand Webinar

AAPS eChalk Talk: Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program

The development of new drugs for rare diseases is a challenging process due to small…

CertaraOctober 12, 2023

Press Release

Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference

PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader…

CertaraOctober 11, 2023

Publication

Regulatory initiatives for artificial intelligence applications: Regulatory writing implications

Medical Writing | Volume 32, Issue 3 - Artificial Intelligence and Machine LearningAuthor: Anjana Bose…

CertaraOctober 11, 2023

Announcement

Certara Acquires Formedix LLC to Increase Data Standardization Across Clinical Trials for Faster Study Setup, Time to Analysis and Submissions

Formedix ryze cloud based clinical metadata repository and SDTM automation suite and Certara Pinnacle 21…

CertaraOctober 10, 2023

Blog

Do the Scale-up & Post approval Changes (SUPAC) Guidance Documents Still Apply to Drug Developers?

Do you remember the 1990s? The Soviet Union fell, Friends was the most popular TV…

CertaraOctober 6, 2023

pre-update

Streamlining Pharmacokinetic Data Management with Certara’s Integral

How Biosimulation & AI Tech Could Solve Pharma’s R&D Productivity Crisis

Certara QSP Designer Technology

Advancing Rectal Drug Delivery: A Breakthrough in Physiologically Based Pharmacokinetic Modeling

RAPS Sponsored Webcast: Leveraging Today’s Technology to Accelerate Submissions: Real Life Examples and Lessons Learned

AAPS eChalk Talk: Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program

Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference

Regulatory initiatives for artificial intelligence applications: Regulatory writing implications

Certara Acquires Formedix LLC to Increase Data Standardization Across Clinical Trials for Faster Study Setup, Time to Analysis and Submissions

Do the Scale-up & Post approval Changes (SUPAC) Guidance Documents Still Apply to Drug Developers?

Newsletter sign up

Quick links

Solutions

Contact